AzTrials
AzTrials

Motivational InterviewingMOTIVAPNCT06235307

Motivational Interviewing and Practice of Physical Activity in Patients With ALD

A study testing motivational interviewing in people with Motivational Interviewing and Chronic Disease, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Since 2017, ALD patients can be prescribed Adapted Physical Activity (APA) on prescription. However, this possibility of prescription remains relatively unknown and little used by doctors, while the benefits of APA in particular in chronic diseases are well established and 30% of adults in France do not reach the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Motivational Interviewing, Chronic Disease
What is being tested?
motivational interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
114 participants
Where
1 siteFrance
Study dates
11 Dec 2023to 2 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with chronic disease (ALD)
  • aged 18 and over, autonomous in their ability to move
  • living in the metropolis of Amiens

Who cannot join

  • contraindication to the practice of physical activity;
  • patient under guardianship, curators,
  • safeguard of justice ;
  • patient deprived of liberty ;
  • pregnant woman ;
  • patient who not benefiting from a social security scheme

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Universitaire d'Amiens

    Amiens, Picardie, 80000

Other trials in France

About this study

Official title: Effects of Motivational Interviewing on Compliance With Physical Activity Practice in Patients With Chronic Disease in the City of Amiens

Since 2017, ALD patients can be prescribed Adapted Physical Activity (APA) on prescription. However, this possibility of prescription remains relatively unknown and little used by doctors, while the benefits of APA in particular in chronic diseases are well established and 30% of adults in France do not reach the recommendations of WHO on physical activity. These obstacles to prescription are well known thanks to studies on the subject (lack of information on Sport-Health networks, lack of training in APA prescription, poor financial support, lack of support for deliver to patients).

To overcome this lack of implementation, the city of Amiens, via the Office des Sports d'Amiens Métropole (OSAM), has implemented since September 2022 tools to help prescribe APA: blocks pre- filled certificates of absence of contraindication and prescription of adapted physical activity.

In other areas of health, such as breastfeeding, performing motivational interviewing has improved patient compliance. Patients with chronical disease consult a doctor from the Amiens metropolitan area recruited beforehand who informs them of the existence of the physical activity promotion program of Amiens Métropole. After obtaining their consent and establishing a certificate of no contraindication, the patients will be randomized by a random draw into two groups: motivational interviewing (ME) and control group (GT). Upon entry into the program, all patients will be seen for an assessment of their physical condition at the premises of Amiens Métropole by a teacher in adapted physical activity (APA) in order to be assessed and directed to a club or a approved associations. The EM group will also benefit from a motivational interview at 0 and 3 months by a doctor trained in the technique. The entire cohort will complete the SF12 (perception of quality of life) and IPAQ (current level of physical activity) questionnaires at 0 and 6 months during the usual appointments with the APA teacher.

Being tested
motivational interviewing
Keywords
motivational interviewing, physical activity practice, Chronic Disease, IPAQ score, SF12 score
Medical subject headings
Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • motivational interviewingOther

    Upon entry into the program, all patients will be seen for an assessment of their physical condition at the premises of Amiens Métropole by a teacher in adapted physical activity (APA) in order to be assessed and directed to a club or a approved associations. The EM group will also benefit from a motivational interview at 0 and 3 months by a doctor trained in the technique. The entire cohort will complete the SF12 (perception of quality of life) and IPAQ (current level of physical activity) questionnaires at 0 and 6 months during the usual appointments with the APA teacher.

Study groups in NCT06235307
Study groupRoleWhat they receive
motivational interviewingExperimentalNot described
Receives: Other: motivational interviewing
ControlActive comparatorNot described
Receives: Other: motivational interviewing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change from baseline of the IPAQ score

    IPAQ is the International Physical Activity Questionnaire Measurement of the evolution of the IPAQ score of patients according to participation in motivational interviewing

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2024
  2. Study start11 Dec 2023
  3. Primary completion2 Oct 2025
  4. Study completion2 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
114 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06235307
Sponsor's protocol ID
PI2023_843_0092
Acronym
MOTIVAP
Status last verified
May 2025
First submitted
9 Jan 2024
Last updated
31 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing motivational interviewing in people with Motivational Interviewing and Chronic Disease, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change from baseline of the IPAQ score (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in